Core Laboratories Inc. (NYSE:CLB – Get Free Report) announced a quarterly dividend on Wednesday, February 4th. Stockholders of record on Monday, February 16th will be given a dividend of 0.01 per share by the oil and gas company on Monday, March 9th. This represents a c) annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, February 13th.
Core Laboratories has decreased its dividend payment by an average of 0.6%annually over the last three years. Core Laboratories has a dividend payout ratio of 4.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Core Laboratories to earn $1.11 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 3.6%.
Core Laboratories Stock Down 10.5%
Shares of CLB stock traded down $2.06 during mid-day trading on Thursday, reaching $17.55. 54,823 shares of the company’s stock traded hands, compared to its average volume of 336,859. The company has a quick ratio of 1.76, a current ratio of 2.37 and a debt-to-equity ratio of 0.41. The company’s 50-day moving average price is $17.62 and its 200-day moving average price is $14.41. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $20.36. The company has a market cap of $817.13 million, a P/E ratio of 26.19, a P/E/G ratio of 17.14 and a beta of 1.09.
Core Laboratories Company Profile
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Featured Articles
- Five stocks we like better than Core Laboratories
- The day the gold market broke
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Trump Planning to Use Public Law 63-43: Prepare Now
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
